Is NBIX up or down today?
NBIX is down 3.84% today, last at 159.68. This stock moved -3.84% versus the prior close.
NBIX · NBIX
NBIX (NBIX) is trading at 159.68, down 3.84% on the session. NBIX carries a 14-day RSI of 65, and trades above its 50-day average. Over the past month it is up 9.74%.
Leading the coverage: “Exelixis (EXEL) vs. BMRN and NBIX: Can CABOMETYX and Pipeline Growth Revive Investor Confidence?” (Insider Monkey, 7d ago). NBIX is +9.09% since story.
NBIX trades on a trailing P/E of 47.1 and is running 15.44% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
NBIX is down 3.84% today, last at 159.68. This stock moved -3.84% versus the prior close.
Leading the coverage: “Exelixis (EXEL) vs. BMRN and NBIX: Can CABOMETYX and Pipeline Growth Revive Investor Confidence?” (Insider Monkey, 7d ago). NBIX is +9.09% since story. Dominant story: Neurocrine Biosciences Presents New Tardive Dyskinesia Survey Results Showing Fewer Work and School Disruptions with INGREZZA® (valbenazine) Capsules (1 source, neutral) RSI is 65 — leaning bullish Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Nov 2026 (125 days) · Drag or scroll left for earlier dates
Neurocrine Biosciences Presents New Tardive Dyskinesia Survey Results Showing Fewer Work and School Disruptions with INGREZZA® (valbenazine) Capsules
Neurocrine Biosciences: 3 Growth Drivers And An Attractive Valuation (NASDAQ:NBIX) - Seeking Alpha
What Lifted Neurocrine Biosciences (NASDAQ:NBIX), Revvity (NYSE:RVTY), IDEXX Laboratories (NASDAQ:IDXX) and Tempus AI (NASDAQ:TEM) as Much as 22%? - Kalkine
What Lifted Neurocrine Biosciences (NASDAQ:NBIX) 13.4% as Crenessity Sales Doubled? - Kalkine
Neurocrine Biosciences: Up 15% After Q3, The Research Engine Is Still Almost Free (NBIX) - Seeking Alpha